ITF Therapeutics, the U.S. affiliate of Italfarmaco, has announced publication of positive long-term safety and efficacy data for givinostat as a treatment for Duchenne muscular dystrophy (DMD).
Indero explore how Lean Six Sigma (LSS) principles are being adapted from manufacturing industries to deliver clinical trials faster, more efficiently, and with greater consistency.
RenovoRx, a life sciences company developing innovative targeted oncology therapies and commercialising RenovoCath, a patented, FDA-cleared drug-delivery device, has announced the launch of the PanTheR Post-Marketing Registry Study (NCT06805461).
Xeltis has announced encouraging preliminary data for Xabg, its coronary artery bypass conduit (CABG), demonstrating positive safety and patency among patients with multi-vessel atherosclerotic coronary artery disease.
PSI CRO explores solid site relationships and how they are the backbone of successful clinical trials. Without happy, supported sites, enrolment simply cannot happen predictably or within budgetary constraints.
PSI, a global Contract Research Organisation, explains why selecting a global safety database is one of the most critical decisions in managing clinical trial data.
Keystone Folding Box Co., a provider of paperboard packaging solutions, has announced a strategic partnership with Med-Con Technologies, a global provider of clinical trial adherence technology solutions.
Dr. Werner Engelbrecht, senior director strategy, Veeva Systems explores how this year could see clinical trial innovation surge as EU regulation evolves.
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
CluePoints, the sponsor of RBQMLive and provider of statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual RBQMLive.
